A woman has filed a lawsuit within the Benicar multidistrict litigation alleging the pharmaceutical drug caused her to develop Benicar intestinal damage.

Plaintiff Rhonda J. recently filed her complaint against Daiichi Sankyo, manufacturer of the antihypertensive medication Benicar. Her complaint is filed within MDL No. 2606 in the U.S. District Court in New Jersey.

Currently, as of the most recent summary on the Judicial Panel on Multidistrict Litigation website, 1,749 lawsuits are pending against Daiichi Sankyo, with complaints of personal gastrointestinal injuries, including Benicar intestinal damage.

Rhonda is a California resident who is 55 years of age. Rhonda claims that she began taking Benicar and Benicar HCT in 2013 under the supervision of her physician.

As a result of taking Benicar, Rhonda alleges she suffered injuries that were personal and economic in nature including, but not limited to, “nausea, diarrhea, vomiting, abdominal pain/discomfort, malabsorption, fatigue, malnutrition, dehydration, inflammation, villous damage/atrophy/blunting, sprue -like enteropathy, olmesartan associated enteropathy, colitis, intestinal injury and damage, medical expenses.”

The plaintiff has brought forth a number of allegations against the drug’s manufacturer following her Benicar intestinal damage including products liability for design defect and failure to warn, multiple counts of negligence, negligent misrepresentation, negligent design, fraudulent concealment, constructive fraud, fraud, breaches of express and implied warranties, unjust enrichment, violation of California consumer protection laws and punitive damages.

Rhonda is seeking relief and judgment in the form of compensatory damages, punitive damages, interest, costs of suit and any additional relief that the Court deems appropriate.

Benicar Intestinal Damage

Benicar (olmesartan) is a prescription medication used to treat high blood pressure in individuals. The medication works by dilating blood vessels so that the blood can flow more freely, reducing the strain and pressure and easing the demand on the heart.

While the medication has been found to be very useful in many patients who have not had their blood pressure successfully lowered by other means, the drug is not without risk.

The majority of complications and side effects that arise from the use of the drug impact the body’s gastrointestinal tract.

Many patients visit their doctor with complaints of symptoms mirroring that of celiac disease, a severe allergy to gluten, the protein found in barley, wheat and rye. However, most patients test negative for the condition.

What has been found are related conditions known as villous atrophy and malabsorption. Together, in the absence of celiac disease, these cause a condition referred to as sprue-like enteropathy.

The Benicar intestinal damage experienced by patients is more specifically referred to as a drug-induced sprue-like enteropathy.

Patients experiencing these gastrointestinal complications may suffer from malabsorption, malnutrition, severe diarrhea that leads to electrolyte imbalance and dehydration which may result in hospitalization and other conditions related to the Benicar intestinal damage.

Filing a Benicar Intestinal Damage Lawsuit

If you or a loved one has suffered from Benicar intestinal damage as a result of taking the antihypertensive medication, you may be eligible to file a lawsuit to pursue damages related to physical, emotional and economic injury.

A Benicar attorney can conduct a complimentary case review and help you decide if taking legal action against the product’s manufacturer is right for you.

The Benicar Intestinal Damage Lawsuit is Case No. 1:33-cv-2606, in the U.S. District Court for the District of New Jersey, Camden Vicinage.